While MGMT methylation status was not found to be a significant factor in predicting survival, we nevertheless fitted it into the clinical model since it has been found to be an important prognostic marker of glioblastoma in a wide body of literature [5, 27, 28]. This evidence concerns the gene MGMT and glioblastoma.